The third seminar of our online, integrated educational course explores topics relevant to the treatment of renal cell carcinoma. Originally held on September 13, 2012, Part III features Drs Thomas E Hutson and Robert J Motzer.
Results from a renal cell oncology Patterns of Care survey of 150 randomly selected US-based medical oncologists in practice and descriptions of key ongoing clinical trials in RCC in the adjuvant and metastatic settings.
Featuring a roundtable discussion with Drs Ronald M Bukowski, Toni K Choueiri, Daniel J George and Robert J Motzer focused on the treatment of RCC developed in conjunction with the Florida Cancer Specialists. (Text and Audio Content)
Journal club program highlighting recent advances in renal cell cancer research. Each journal club should take five minutes to complete and is comprised of an abbreviated slide set along with edited commentary.
Sunitinib Continuous 37.5 mg/Day Dosing in Cytokine-Refractory Metastatic RCC andPazopanib in Patients with Treatment-Naïve or Cytokine-Pretreated Advanced RCC
Edited proceedings from closed roundtable discussions among clinical investigators debating newly published data and controversial issues central to patient care.
Roundtable participants include Drs Michael B Atkins, Robert A Figlin, Thomas E Hutson, Eric Jonasch, Robert J Motzer and David I Quinn. (Text and Audio Content)
Recorded discussions from case-based meetings featuring community oncologists presenting actual but de-identified cases to a panel of clinical investigators.
